Abiopharma

New Form 8-K - BriaCell Therapeutics Corp. Filed: 2025-07-16 AccNo: 0001641172-25-019892 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits